Oncotarget- A Medical Journal Availing Scientific Results

Oncotarget is a journal that appreciates the interdependence of disciplines in the biomedical profession. The journal does not have a restricted access and as such researchers and science professionals can access the articles published. The materials on this journal are edited by two biomedical professionals: Andrei V. Gudkov and Mikhail Blagosklonny. The publication of the material is done on a weekly basis.

Mission

Oncotarget is dedicated to disseminating scientific material and results of research. Once the results are verified, it follows that they are then published for all, in the scientific world, to access. The journal also publishes exceptional discoveries so that others can learn and make critical contributions.

At the heart of the journal is the desire to eliminate the barriers and limitations that exist between the many scientific specialties. Another of the aspirations the journal has is to bring together the many professionals in the biomedical field. Indeed, the journal also pushes for the application of fundamental clinical science to aid in the combating of diseases. The journal, under the leadership of established science professionals, helps researchers make scientific contributions to grow science. Learn more about Oncotarget at Research Gate.

The Editorial Leadership

The materials sent to Oncotarget are edited by a team of editors led by Andrei Gudkov and Mikhail Blagosklonny. Andrei is an authority in experimental and molecular biology. He is also versed in oncology. Andrei Gudkov went to Moscow State University where he excelled in these areas of science. Andrei is the Cleveland Biolabs co-founder and doubles as the principal scientific officer for the labs. Gudkov is also the founder of Tartis. His area of specialty is both in gene and drug research.

Mikhail Blagosklonny is the other chief editor of the journal Oncotarget. He is an expert in cellular biology, but also has his share of expertise in molecular biology. He studies anti-cancer therapeutics, signal transduction, cell cycle and cellular senescence. Mikhail is also Cell Cycle’s Editor-in- Chief.

Guideline for Authors

Writers, making submissions to Oncotarget, have to bear in mind that the journal is especially interested in cancer research. It is also interested in material on oncology. Since cancer is dynamic in nature, the journal also publishes articles on age-related diseases, physiology, immunology endocrinology and pathology. Check Oncotarget journal at scimagojr.com